Eye imaging study for premature infants at risk of retinopathy
Part of Eyes & vision, Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is less than 35 weeks of corrected age (age since last menstrual period) at their first visit.
- Your baby is eligible for routine retinopathy of prematurity screening based on guidelines from the American Academy of Pediatrics.
- You, as the parent or legal guardian, are willing to allow the study team to contact you and to give consent for your baby to join.
- If your baby is transferred to a nursery for retinopathy treatment, they may also be included.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study looks at long-term eye health in people who were born prematurely and had retinopathy of prematurity (ROP) screening as babies. It aims to understand how the eyes develop over many years.
This study looks at how laser or injection treatments for retinopathy of prematurity (ROP) affect vision and eye health later in life. It also includes children who had ROP but did not need treatment.
This study uses pictures to map the tiny blood vessels in an infant’s retina (the back of the eye). It may help researchers better understand how eye blood vessel growth happens in premature babies who need screening for ROP (retinopathy of prematurity).
This study looks at eye structure in children who were in an earlier premature-baby eye study and are now around 4.5–5 years old. It may help researchers better understand how eye disease in prematurity develops and how to monitor it.
This study tests a new type of eye imaging to better detect and diagnose early-onset retinal dystrophies in children up to 8 years old. It may help find these conditions sooner and guide treatment.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.